BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cottone C, Bhamidimarri KR. Evaluating CKD/ESRD patient with hepatitis C infection: How to interpret diagnostic testing and assess liver injury. Semin Dial 2019;32:119-26. [PMID: 30599462 DOI: 10.1111/sdi.12760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bloom RD, Roth D. Introduction to hepatitis C virus infection in patients with kidney disease: A roadmap for nephrologists. Semin Dial 2019;32:91-2. [PMID: 30827039 DOI: 10.1111/sdi.12775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Taneja S, Duseja A, Mehta M, De A, Verma N, Premkumar M, Dhiman RK, Singh V, Singh MP, Ratho RK, Ramachandran R, Kumar V, Kohli HS. Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end-stage renal disease on maintenance haemodialysis. Liver Int. 2021;41:705-709. [PMID: 33025685 DOI: 10.1111/liv.14685] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
3 Eames JR, Tran B. Hepatitis C. Physician Assistant Clinics 2021;6:555-68. [DOI: 10.1016/j.cpha.2021.05.002] [Reference Citation Analysis]